Results 171 to 178 of about 98,224 (178)

A Multicentre, Randomised Phase II Study of Weekly or 3-Weekly Docetaxel in Patients With Metastatic Breast Cancer

Annals of Oncology, 2004
Josep Tabernero Caturla, J Albanell, J B Vermorken   +2 more
exaly  

Phase II Study of Weekly Docetaxel in Patients With Metastatic Breast Cancer

Annals of Oncology, 2002
Y Takatsuka, T Aihara
exaly  

Overall Survival Benefit for Sequential Doxorubicin–Docetaxel Compared With Concurrent Doxorubicin and Docetaxel in Node-Positive Breast Cancer—8-Year Results of the Breast International Group 02-98 Phase III Trial

Annals of Oncology, 2013
Martine Piccart, Prudence Francis, R D Gelber   +2 more
exaly  

Sequential Two-Line Strategy for Stage IV Non-Small-Cell Lung Cancer: Docetaxel–Cisplatin Versus Vinorelbine–Cisplatin Followed by Cross-Over to Single-Agent Docetaxel or Vinorelbine at Progression: Final Results of a Randomised Phase II Study

Annals of Oncology, 2005
A Monnier, Radj Gervais, J -Y Douillard
exaly  

Docetaxel

Reactions Weekly, 2003
openaire   +1 more source

Docetaxel

Reactions Weekly, 2002
openaire   +1 more source

Docetaxel

Reactions Weekly, 2008
openaire   +1 more source

Docetaxel

Reactions Weekly, 2009
openaire   +1 more source